title: 8-Isoprostane and Coenzyme Q10 Levels in Patients with Metabolic Syndrome.
abstract: Metabolic syndrome has become an important health problem, which involves obesity, hyperlipidemia, insulin resistance, and high blood pressure values. The components of metabolic syndrome are all suggested as independent cardiovascular disease risk factors along with high mortality and morbidity rates accompanied by many organ and system complications.
  
  
  
  We aimed to determine 8-isoprostane (8-IsoP) and coenzyme Q10 (CoQ10) levels in patients with metabolic syndrome and healthy individuals and demonstrate whether there was any relation between these parameters and metabolic syndrome criteria.
  
  
  
  A total of 30 patients (10 male, 20 female) with metabolic syndrome and 20 age-matched healthy individuals (9 male, 11 female) were involved in the study. Body mass index, waist and hip circumferences, systolic and diastolic blood pressures and serum glucose, triglyceride, total cholesterol, high-density lipoprotein cholesterol, insulin, HbA1c, 8-IsoP and CoQ10 levels, and homeostasis model assessment of insulin resistance indexes of all participants were determined.
  
  
  
  8-IsoP levels were significantly increased in metabolic syndrome compared to healthy individuals (P = 0.003), however, there was no significant difference between groups for CoQ10 levels. 8-IsoP levels were positively correlated with waist circumference (r = 0.303, P = 0.032), diastolic blood pressure (r = 0.337, P = 0.017), systolic blood pressure (r = 0.329, P = 0.020) values and total cholesterol levels (r = 0.354, P = 0.012).
  
  
  
  We can suggest that the levels of 8-IsoP, which is an indicator of the oxidative stress, increase in metabolic syndrome and this can be associated with high blood pressure and visceral adiposity, which are the components of metabolic syndrome.
authors.affiliation: 1 Department of Biochemistry, Meram Medical Faculty, Necmettin Erbakan University , Konya, Turkey .
authors.forename: Humeyra
authors.initials: H
authors.lastname: Ercan
authors.affiliation: 2 Department of Biochemistry, Medical Faculty, Mevlana University , Konya, Turkey .
authors.forename: Aysel
authors.initials: A
authors.lastname: Kiyici
authors.affiliation: 3 Department of Family Medicine, Selcuk University , Konya, Turkey .
authors.forename: Kamile
authors.initials: K
authors.lastname: Marakoglu
authors.affiliation: 2 Department of Biochemistry, Medical Faculty, Mevlana University , Konya, Turkey .
authors.forename: Mufide
authors.initials: M
authors.lastname: Oncel
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure; D015992:Body Mass Index; D016022:Case-Control Studies; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000097:blood; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D050152:Intra-Abdominal Fat / Q000473:pathology; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood*; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D014280:Triglycerides / Q000097:blood; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000097:blood; D055105:Waist Circumference
chemical_list: D014280:Triglycerides; D014451:Ubiquinone; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost; C024989:coenzyme Q10